Endava plc (NYSE:DAVA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the ten brokerages that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $42.31.
A number of research firms have weighed in on DAVA. Guggenheim decreased their target price on shares of Endava from $55.00 to $45.00 and set a "buy" rating for the company in a research report on Monday, September 16th. Needham & Company LLC decreased their price objective on shares of Endava from $42.00 to $33.00 and set a "buy" rating for the company in a research report on Friday, September 20th. JPMorgan Chase & Co. boosted their target price on shares of Endava from $41.00 to $47.00 and gave the company an "overweight" rating in a report on Friday, September 6th. Finally, Susquehanna decreased their price target on Endava from $66.00 to $55.00 and set a "positive" rating for the company in a report on Friday, September 20th.
Check Out Our Latest Analysis on Endava
Endava Trading Down 0.7 %
Shares of Endava stock traded down $0.17 during trading on Friday, hitting $24.82. The company's stock had a trading volume of 219,964 shares, compared to its average volume of 529,538. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of 27.58 and a beta of 1.21. Endava has a 52 week low of $23.28 and a 52 week high of $81.06. The stock has a 50-day moving average price of $28.16 and a two-hundred day moving average price of $28.96. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.74 and a quick ratio of 1.74.
Endava (NYSE:DAVA - Get Free Report) last announced its earnings results on Thursday, September 19th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.13). The company had revenue of $245.30 million for the quarter, compared to analyst estimates of $248.65 million. Endava had a return on equity of 2.76% and a net margin of 2.30%. Equities research analysts anticipate that Endava will post 0.77 EPS for the current fiscal year.
Institutional Trading of Endava
Institutional investors have recently made changes to their positions in the company. Blue Trust Inc. bought a new position in shares of Endava in the third quarter valued at approximately $30,000. Headlands Technologies LLC bought a new position in Endava in the 1st quarter valued at $49,000. Signaturefd LLC increased its position in shares of Endava by 84.1% during the 3rd quarter. Signaturefd LLC now owns 1,939 shares of the company's stock valued at $50,000 after purchasing an additional 886 shares during the last quarter. Seven Eight Capital LP bought a new stake in shares of Endava during the 2nd quarter worth $216,000. Finally, Precision Wealth Strategies LLC raised its stake in shares of Endava by 6.7% during the 3rd quarter. Precision Wealth Strategies LLC now owns 8,571 shares of the company's stock worth $219,000 after purchasing an additional 540 shares during the period. Institutional investors own 62.23% of the company's stock.
About Endava
(
Get Free ReportEndava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.